RevBio Awarded Funding to Conduct an In Vivo Bone Experiment on the International Space Station

Astronaut Joe Acaba works with RevBio’s first in vitro bone cell experiment on board the International Space Station U.S. National Laboratory in 2018. This new experiment will be an in vivo experiment using mice to study the company’s bone adhesive biomaterial and its ability to facilitate bone repair, especially under osteoporotic conditions induced by the micro-gravity environment of outer space. (Credit: NASA)

This unique opportunity will allow the Company to expand its research on its osteoconductive bone adhesive biomaterial.

LOWELL, Mass., March 9, 2021 (RevBio PR) — RevBio, Inc., announced that it has been awarded the opportunity to conduct an in vivo research experiment on the International Space Station U.S. National Laboratory (ISS National Lab). This experiment will examine the biomaterial’s osteoconductivity when used in a microgravity environment where bone density and the ability to regenerate new bone tissue is significantly compromised.